Table 1.
Baseline demographics and disease characteristics.
| Variable | n | % |
|---|---|---|
| Study cohort | 26 | 100% |
| Sex | ||
| Female | 23 | 88% |
| Male | 3 | 12% |
| ECOG performance status score | ||
| 0 | 20 | 77% |
| 1 | 5 | 19% |
| Not available | 1 | 4% |
| Tumor site | ||
| Superficial AS | 18 | 69% |
| Visceral AS | 8 | 31% |
| Tumor origin | ||
| Primary AS | 13 | 50% |
| Secondary AS | 13 | 50% |
| Disease status at presentation | ||
| Locally advanced | 5 | 19% |
| Metastatic | 21 | 81% |
| Liver | 9 | 35% |
| Bone | 7 | 27% |
| Lung | 6 | 23% |
| Lymph nodes | 3 | 12% |
| Other | 9 | 35% |
| Prior treatments | ||
| Surgery | 14 | 54% |
| Radiotherapy | 3 | 12% |
| Chemotherapy | 3 | 12% |
| No prior treatments | 11 | 42% |
ECOG, Eastern Cooperative Oncology Group; AS, angiosarcoma.